The Tolvaptan Era: Driving Innovation in ADPKD Management

σε πρόσθεσε στο Health

2025-12-09 13:09:20 -

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary renal disease, leading inevitably to kidney failure in a significant portion of patients. For decades, treatment focused primarily on symptom management, including controlling hypertension with ACE inhibitors and ARBs, and addressing pain or infections. However, the paradigm shifted dramatically with the...

0 Σχόλια 0 Μοιράστηκε 405 Views 0 Προεπισκόπηση